Stability of Cimetidine HCl and Copper Sulfate in a TPN Solution

Mu-Chow KJ Baptista RJ . Cost-effectiveness of parenteral nutrient solutions containing cimetidine hydrochloride (letter). Am J Hosp Pharm 1984; 41: 1321,4.

Schneider PJ Mirtallo JM . Medication profiles in TPN patients. Nutr Support Serv 1983; 3: 40–3.

Tsallas G Allen LC . Stability of cimetidine hydrochloride in parenteral nutrition solutions. Am J Hosp Pharm 1982; 39: 484–5.

Baptista RJ Palombo JD Tahan SR Stability of cimetidine hydrochloride in a total nutrient admixture. Am J Hosp Pharm 1985; 42: 2208–10.

Williams SK Baptista RJ Echenque MM Dosing cimetidine HCl as a continuous infusion via parenteral nutrient solutions. Infusion 1985; 9: 45–7, 54.

Ostro MJ Russel JA Soldin SJ Control of gastric pH with cimetidine: boluses versus primed infusions. Gastroenterology 1985; 89: 532–7.

Greenaway FT Brown LM Dabrowiak JC Copper (II) complexes of the antiulcer drug cimetidine. J Am Chem Soc 1980; 102: 7782–4.

Smith Kline & French Laboratories. Tagamet HCl injection compatibility and stability information. TG:L59. Philadelphia, PA: August 1985.

Newton DW . Physicochemical determinants of incompatibility and instability in injectable drug solutions and admixtures. In: Trissell LA . Handbook on injectable drugs. 2nd ed. Washington DC: American Society of Hospital Pharmacists, 1980: xv–xxxi.

Bartlett JC Segelman AB . Bioanalysis of cimetidine by high-performance liquid chromatography. J Chromatogr 1983; 255: 239–45.